Trial Profile
A Phase 1 Trial of an Autologous Neo-Kidney Augment in Patients with Chronic Kidney Disease in Sweden.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 Jul 2015
Price :
$35
*
At a glance
- Drugs Rilparencel (Primary)
- Indications Renal failure
- Focus Adverse reactions
- 22 Jan 2014 New trial record